This event will feature live presentations from life sciences executives addressing various investment opportunities in Biopharma, Biotech, Medtech and Infant Nutrition.
Thursday, September 15th Agenda
Starpharma Holdings Ltd.
OTCQX: SPHRY | ASX: SPL
Industry: Biopharma
Jackie Fairley, CEO
VolitionRx Limited
NYSE American: VNRX
Industry: Epigenetics: Cancer Screening/Veterinary
Scott Powell, Head of Investor Relations & U.S. Chief Financial Officer
aTyr Pharma, Inc.
Nasdaq: LIFE
Industry: Biotherapeutics: tRNA Synthetase platform
Ashlee Dunston, Director of Investor Relations & Corporate Communications
Cloud DX Inc.
OTCQB: CDXFF | TSX-V: CDX
Industry: Medtech: Remote Monitoring
Robert Kaul, CEO, President & Chair of the Board
Cytonics Corporation
Private Company
Industry: Biotech: Osteoarthritis
Joey Bose, President & Board Member
BioHarvest Sciences Inc.
OTCQB: CNVCF | CSE: BHSC
Industry: Biotech: Bio-cell Growth Platform
Ilan Sobel, CEO
NovaBay Pharmaceuticals, Inc.
NYSE American: NBY
Industry: Biopharma: Ophthalmology and Dermatology
Justin Hall, CEO
Andrew Jones, CFO
Psycheceutical Bioscience, Inc.
OTC Pink: BWVI
Industry: Biopharma: Psychedelic Mental health Treatment
Chad Harman, CEO
Else Nutrition Holdings Inc.
OTCQX: BABYF | TSX: BABY
Industry: Plant-Based Nutrition
Hamutal Yitzhak, Co-Founder and CEO
Lisata Therapeutics
Nasdaq: LSTA
Industry: Biopharma: Cellular therapies
David Mazzo, President & CEO
HealthBeacon PLC
OTCQX: HBCNF | Euronext Dublin: HBCN
Industry: Medtech: Digital Therapeutics
Jim Joyce, CEO & Co-Founder